Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $19.18M | $44.32M | -56.72% |
Operating Income | $-209.03M | $-201.08M | -3.95% |
Net Income | $-91.05M | $-82.78M | -10.00% |
EPS (Basic) | $-2.31 | $-2.41 | +4.15% |
EPS (Diluted) | $-2.31 | $-2.41 | +4.15% |
R&D Expense | $171.86M | $197.25M | -12.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.26B | $1.35B | -6.84% |
Current Assets | $1.03B | $1.09B | -5.97% |
Total Liabilities | $407.17M | $542.24M | -24.91% |
Current Liabilities | $177.33M | $209.54M | -15.37% |
Stockholders' Equity | $854.09M | $811.64M | +5.23% |
Cash & Equivalents | $292.76M | $225.54M | +29.80% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-182.76M | $-194.48M | +6.03% |
Investing Cash Flow | $34.03M | $-16.03M | +312.30% |
Financing Cash Flow | $3.03M | $205.96M | -98.53% |
D&A | $11.01M | $9.46M | +16.32% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1089.7% | -453.7% | -636.05% |
Net Margin | -474.7% | — | — |
ROE | -10.7% | — | — |
ROA | -7.2% | — | — |
Current Ratio | $5.805 | — | — |
Debt to Equity | $0.477 | — | — |
Other companies in Biotechnology